SAN DIEGO, Aug. 3, 2022 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference® (AAIC®) 2022 covered the breadth of Alzheimer's and dementia research, including the basic biology of ...
SAN ANTONIO, June 8, 2022 /PRNewswire/ -- The University of Texas at San Antonio (UTSA) today announced the 10 recipients of the Oskar Fischer Prize, an international competition to expand ...
Investment by the ADDF will accelerate the translation of Molecular Stethoscope's cf-mRNA liquid biopsy technology platform into products and services for the diagnosis and management of Alzheimer's disease SOUTH SAN FRANCISCO, ...
LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer's based on published researchSafety profile is favourable and consistent with previous HMTM ...
PRESS RELEASE reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a Leuven Belgium, 03 May 2022: reMYND NV, a clinical stage ...
BOTHELL, Wash., March 20, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, ...
Oral presentation on preclinical data demonstrates Prothena’s dual Aβ/tau vaccine, for the potential treatment and prevention of Alzheimer’s, generated anti-Aβ and anti-tau antibodies to enable phagocytosis of Aβ and to ...
Oral presentation on neurotrophic and procognitive properties of the active metabolite of fosgonimeton in preclinical models First presentation of preclinical data from ATH-1020 candidate for neuropsychiatric conditions BOTHELL, Wash., Feb. ...
Leading academic lab harnesses Simoa digital biomarker analysis technology providing up to 1000x greater sensitivity than traditional immunoassays Powering Precision Health 2022 Alzheimer’s podcast announced in recognition of Biomarker Factory ...
JUPITER, Fla., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying, and ...
Copyright © 2015 - 2021 Lifecarenews.in
